Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 + T cell response
Science Immunology · 04.10.2024 · 9 (100)
DOI: 10.1126/sciimmunol.adq8843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 04.10.2024. Verfasst von Aleksey Chudnovskiy und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Lymphocyte Dynamics, Rockefeller University, New York, NY, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Dendritic Cells, Mice, Inbred C57BL. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HSRD VA.
Abstract (Originalsprache)
Dendritic cells (DCs) are uniquely capable of transporting tumor antigens to tumor-draining lymph nodes (tdLNs) and interact with effector T cells in the tumor microenvironment (TME) itself, mediating both natural antitumor immunity and the response to checkpoint blockade immunotherapy. Using LIPSTIC (Labeling Immune Partnerships by SorTagging Intercellular Contacts)–based single-cell transcriptomics, we identified individual DCs capable of presenting antigen to CD4 + T cells in both the tdLN and TME. Our findings revealed that DCs with similar hyperactivated transcriptional phenotypes interact with helper T cells both in tumors and in the tdLN and that checkpoint blockade drugs enhance these interactions. These findings show that a relatively small fraction of DCs is responsible for most of the antigen presentation in the tdLN and TME to both CD4 + and CD8 + tumor–specific T cells and that classical checkpoint blockade enhances CD40-driven DC activation at both sites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Lymphocyte Dynamics, Rockefeller University, New York, NY, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Harvard School of Dental Medicine, Harvard University, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- School of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
- Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
ORCID-Profile: Aleksey Chudnovskiy, Ang Cui, Moshe Sade-Feldman, Brooke K Phillips, Luka Mesin, Juliana Bortolatto, Giulia Pasqual, Li-Fan Lu, Nir Hacohen, Gabriel D Victora
Förderung
- NIAID NIH HHS
- HSRD VA
Zitieren
APA
Chudnovskiy, A., Castro, T. B. R., Nakandakari-Higa, S., Cui, A., Lin, C. H., Sade-Feldman, M., Phillips, B. K., Pae, J., Mesin, L., Bortolatto, J., Schweitzer, L. D., Pasqual, G., Lu, L. F., Hacohen, N., & Victora, G. D. (2024). Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 + T cell response. Science Immunology, 9(100). https://doi.org/10.1126/sciimmunol.adq8843
Vancouver
Chudnovskiy A, Castro TBR, Nakandakari-Higa S, Cui A, Lin CH, Sade-Feldman M, et al. Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 + T cell response. Science Immunology. 2024;9(100). doi:10.1126/sciimmunol.adq8843
BibTeX
@article{Chudnovskiy2024,
author = {Chudnovskiy, Aleksey and Castro, Tiago B R and Nakandakari-Higa, Sandra and Cui, Ang and Lin, Chia-Hao and Sade-Feldman, Moshe and Phillips, Brooke K and Pae, Juhee and Mesin, Luka and Bortolatto, Juliana and Schweitzer, Lawrence D and Pasqual, Giulia and Lu, Li-Fan and Hacohen, Nir and Victora, Gabriel D},
title = {Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 + T cell response},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {100},
doi = {10.1126/sciimmunol.adq8843}
}
EUVIMED